Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DNASTAR Awarded Fast-Track Phase I and Phase II SBIR Grant

Published: Wednesday, September 26, 2012
Last Updated: Wednesday, September 26, 2012
Bookmark and Share
Company receives grant award from NIH to support the development of software for clinical research.

DNASTAR® has announced that it has received a Fast-track Phase I and Phase II SBIR grant award from the National Institutes of Health entitled, “Association Analysis Software for Mining Clinical Next-Gen Sequencing Data”.

The funding will support the company’s research and development aimed at expanding its industry-leading sequence assembly and analysis software from broad research usage to the clinical research market.

Tom Schwei, Vice President and General Manager of DNASTAR, commented, “DNASTAR has been a leader in providing sequence assembly and analysis software to life scientists for more than 25 years. The funding under this grant program will be used to accelerate the speed with which we can move from the general research market into the clinical research market. We already have a strong foundation on which to build our clinical research software platform. This new funding will help us move quickly to add key functionality sought by clinical researchers.

“In addition, this grant project will involve several clinical trial studies with numerous collaborators and clinical trial sponsors. We anticipate sequencing hundreds of samples in a number of studies as part of this Fast-track grant project to help address some of the most pressing needs in some key disease areas. This will help ensure that our software meets the needs of clinical researchers in the best possible way.”

Schwei concluded, “This project ties in well with DNASTAR’s long-term strategy, which is to build on our strength in sequencing software for the general research market and expand into a wide range of related fields. Clinical research is but one of those very important areas we are addressing for the future.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Inhibrx Adopts DNASTAR Lasergene Software
Company has announced that the Inhibrx has entered into an agreement supporting an organization-wide site license of DNASTAR Lasergene software.
Wednesday, March 30, 2016
DNASTAR Appoints Pure Health Medical Supplies
Company appoints Purehealth as distributor of molecular biology software in the Middle East.
Thursday, September 24, 2015
DNASTAR Appoints Biotech Del Norte Mexico as Distributor
Biotech del Norte distributes Company’s DNA, RNA and protein sequence analysis software in Mexico.
Wednesday, August 05, 2015
DNASTAR Awarded Antibody Engineering Software SBIR Grant
Company receives Phase II SBIR grant award from the National Institutes of Health.
Tuesday, September 16, 2014
DNASTAR Awarded Structural Biology Software SBIR Grant
Company receives Phase I SBIR grant award from the National Institutes of Health.
Wednesday, June 11, 2014
Wellcome Trust Sanger Institute Adopts DNASTAR Lasergene Software
Wellcome Trust Sanger Institute and DNASTAR have entered into a multi-year software license agreement.
Thursday, December 05, 2013
DMNB Adopts DNASTAR Lasergene Software
New Lasergene software site license agreement for genome sequence assembly and analysis.
Thursday, September 05, 2013
Dalhousie Medicine New Brunswick Adopts DNASTAR Lasergene Software
DMNB has entered into an agreement supporting an enterprise-wide site license of DNASTAR Lasergene software for genome sequence assembly and analysis.
Thursday, September 05, 2013
Eppley Institute Adopts DNASTAR Software
New site license of DNASTAR Lasergene software for use in sequence assembly and analysis.
Thursday, July 04, 2013
DNASTAR Awarded Antibody Engineering SBIR Grant
NIH awarded grant to build antibody engineering software.
Tuesday, May 15, 2012
DNASTAR Partners with Ion Torrent
Ion Torrent offers DNASTAR’s sequence assembly and analysis software products to the customers through the Ion Torrent on-line web store in the collaboration.
Wednesday, February 16, 2011
DNASTAR Software Grant Supports Ion Torrent Awards
Firm will provide licenses of its next-gen sequencing suite of software tools to the two European winners of the extension of the grant program.
Monday, June 14, 2010
DNASTAR Joins BioIT Alliance
BioIT Alliance announces the expansion of the BioIT Alliance program to include DNASTAR.
Thursday, January 28, 2010
DNASTAR and the University of Iowa Sign Lasergene Site License Agreement
Researchers on the University of Iowa campus have gained unlimited access and use of the software for their sequence analysis projects.
Wednesday, January 06, 2010
Wageningen University and DNASTAR Extend Lasergene Site License Agreement
Under the terms of the site license, researchers will have unlimited use of the software for their sequence analysis projects.
Tuesday, November 24, 2009
Scientific News
Unidentified Spectra Detector
New algorithm clusters over 250 million spectra for analysis, such that millions of unidentified peptide sequences can be recognised.
Making Metabolite Identification More Efficient
Metasense combines the industry's most-comprehensive metabolic transformation prediction with efficient analysis of LC/MS analytical measurements to identify, visualize, and report chemical biotransformations.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Applying Deep Learning to Drug Discovery
Researchers train deep neural networks to predict the therapeutic use of large number of multiple drugs using gene expression data obtained from high-throughput experiments on human cell lines.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!